Compound 22 facilitates dephosphorylation of Akt: In order to determine the efficacy of CP22 in ovarian cancer cell lines, Western blot for phosphorylated AKT was performed in SKOV3 and OV90 cells. This evidence concerns the gene AKT1 and ovarian carcinoma.